Home Why Did Merck Spend $4 Billion on a Tiny Biotech Firm?
 

Keywords :   


Why Did Merck Spend $4 Billion on a Tiny Biotech Firm?

2014-06-14 11:42:27| Biotech - Topix.net

Merck & Co. Inc. has had its sights set on conquering the hepatitis C market for a long time now, and the recovering drugmaker is hoping that a small Cambridge, Massachusetts-based biotech company, Idenix Pharmaceuticals, Inc. , can help it move forward in the race to develop a serious competitor to Gilead Sciences' blockbuster treatment, Sovaldi.

Tags: firm spend billion tiny

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »